These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 12637483)

  • 1. General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from the prostate cancer outcomes study.
    Penson DF; Feng Z; Kuniyuki A; McClerran D; Albertsen PC; Deapen D; Gilliland F; Hoffman R; Stephenson RA; Potosky AL; Stanford JL
    J Clin Oncol; 2003 Mar; 21(6):1147-54. PubMed ID: 12637483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-sectional and longitudinal comparisons of health-related quality of life between patients with prostate carcinoma and matched controls.
    Hoffman RM; Gilliland FD; Penson DF; Stone SN; Hunt WC; Potosky AL
    Cancer; 2004 Nov; 101(9):2011-9. PubMed ID: 15452835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality-of-life outcomes for men with prostate carcinoma detected by screening.
    Smith DS; Carvalhal GF; Schneider K; Krygiel J; Yan Y; Catalona WJ
    Cancer; 2000 Mar; 88(6):1454-63. PubMed ID: 10717630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of health-related quality-of-life outcomes for patients with low-risk prostate cancer managed by active surveillance or radiation therapy.
    Banerji JS; Hurwitz LM; Cullen J; Wolff EM; Levie KE; Rosner IL; Brand TC; LʼEsperance JO; Sterbis JR; Porter CR
    Urol Oncol; 2017 May; 35(5):234-242. PubMed ID: 28110975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of treatment on quality of life among men with clinically localized prostate cancer.
    Schapira MM; Lawrence WF; Katz DA; McAuliffe TL; Nattinger AB
    Med Care; 2001 Mar; 39(3):243-53. PubMed ID: 11242319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responsiveness of the University of California-Los Angeles Prostate Cancer Index.
    Bergman J; Saigal CS; Kwan L; Litwin MS
    Urology; 2010 Jun; 75(6):1418-23. PubMed ID: 19589573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life after intensity modulated radiation therapy for localized prostate cancer: comparison with conventional and conformal radiotherapy.
    Namiki S; Ishidoya S; Tochigi T; Kawamura S; Kuwahara M; Terai A; Yoshimura K; Numata I; Satoh M; Saito S; Takai Y; Yamada S; Arai Y
    Jpn J Clin Oncol; 2006 Apr; 36(4):224-30. PubMed ID: 16537689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity does not adversely affect health-related quality-of-life outcomes after anatomic retropubic radical prostatectomy.
    Freedland SJ; Haffner MC; Landis PK; Saigal CS; Carter HB
    Urology; 2005 Jun; 65(6):1131-6. PubMed ID: 15913722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term quality of life in disadvantaged men with prostate cancer on androgen-deprivation therapy.
    Sevilla C; Maliski SL; Kwan L; Connor SE; Litwin MS
    Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):237-43. PubMed ID: 22289781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate operations: long-term effects on sexual and urinary function and quality of life. Comparison with an age-matched control population.
    Deliveliotis C; Liakouras C; Delis A; Skolarikos A; Varkarakis J; Protogerou V
    Urol Res; 2004 Aug; 32(4):283-9. PubMed ID: 15057494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.
    Punnen S; Cowan JE; Chan JM; Carroll PR; Cooperberg MR
    Eur Urol; 2015 Oct; 68(4):600-8. PubMed ID: 25242555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health related quality of life and direct medical care cost in newly diagnosed younger men with prostate cancer.
    Jayadevappa R; Bloom BS; Chhatre S; Fomberstein KM; Wein AJ; Malkowicz SB
    J Urol; 2005 Sep; 174(3):1059-64; discussion 1064. PubMed ID: 16094058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Life after radical prostatectomy: a longitudinal study.
    Litwin MS; Melmed GY; Nakazon T
    J Urol; 2001 Aug; 166(2):587-92. PubMed ID: 11458073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients' perceptions of quality of life after treatment for early prostate cancer.
    Clark JA; Inui TS; Silliman RA; Bokhour BG; Krasnow SH; Robinson RA; Spaulding M; Talcott JA
    J Clin Oncol; 2003 Oct; 21(20):3777-84. PubMed ID: 14551296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality-of-life outcomes in men treated for localized prostate cancer.
    Litwin MS; Hays RD; Fink A; Ganz PA; Leake B; Leach GE; Brook RH
    JAMA; 1995 Jan; 273(2):129-35. PubMed ID: 7799493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radical prostatectomy versus high-dose rate brachytherapy for prostate cancer: effects on health-related quality of life.
    Jo Y; Junichi H; Tomohiro F; Yoshinari I; Masato F
    BJU Int; 2005 Jul; 96(1):43-7. PubMed ID: 15963118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective longitudinal study comparing a radical retropubic prostatectomy and permanent prostate brachytherapy regarding the health-related quality of life for localized prostate cancer.
    Hashine K; Kusuhara Y; Miura N; Shirato A; Sumiyoshi Y; Kataoka M
    Jpn J Clin Oncol; 2008 Jul; 38(7):480-5. PubMed ID: 18621847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individualizing quality-of-life outcomes reporting: how localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function.
    Chen RC; Clark JA; Talcott JA
    J Clin Oncol; 2009 Aug; 27(24):3916-22. PubMed ID: 19620493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life in young men after radical prostatectomy.
    Wright JL; Lin DW; Cowan JE; Carroll PR; Litwin MS;
    Prostate Cancer Prostatic Dis; 2008; 11(1):67-73. PubMed ID: 17519925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life.
    Lane A; Metcalfe C; Young GJ; Peters TJ; Blazeby J; Avery KN; Dedman D; Down L; Mason MD; Neal DE; Hamdy FC; Donovan JL;
    BJU Int; 2016 Dec; 118(6):869-879. PubMed ID: 27415448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.